Stockreport

Contineum Therapeutics to Attend Upcoming Investor Conferences

Contineum Therapeutics, Inc. - Common stock  (CTNM) 
PDF SAN DIEGO--(BUSINESS WIRE)--Contineum Therapeutics, Inc. (NASDAQ: CTNM) (Contineum or the Company), a clinical stage biopharmaceutical company focused on discovering [Read more]